NRG-LU007, also known as “the RAPTOR study”, is a clinical study for people with extensive stage small cell lung cancer (SCLC) that is testing if adding radiation therapy to the usual treatment can extend the time without your cancer growing or spreading. Typically, people with extensive stage SCLC are treated initially with chemotherapy and the immune therapy drug, atezolizumab, followed by atezolizumab alone after chemotherapy is complete. NRG-LU007 is designed to determine if adding radiation therapy to atezolizumab after chemotherapy could improve survival outcomes for people with this type of lung cancer. Previous studies involving extensive stage SCLC patients have shown that adding radiation therapy to immune therapy is safe and have shown benefit .
More information about this particular study is located on ClinicalTrials.gov
Are you interested in joining the study? Find a participating location
Below, you can find FAQs about clinical research and this particular clinical trial.
Talk to your insurance provider and make sure that you understand what your insurance pays for and what it doesn’t pay for if you take part in this clinical trial. Also, find out if you need approval from your plan before you can take part in the study.
You will not be paid for taking part in this study.
Doctors and researchers conduct a clinical study, also called a “clinical trial,” to find better ways to prevent, diagnose, or treat an illness. NRG Oncology is supported by the National Cancer Institute (NCI) and runs clinical studies specifically for patients with cancer or to prevent cancer. Most clinical studies test something we know against something we don’t know. In all situations, these studies are strictly evaluated before they are allowed to be offered to any patient. The study is designed to answer the question that we do not know the answer to, so that current and future patients may have better treatments or information than what we currently have. There are different types of clinical studies that might be available for patients. For more information see “Types of Clinical Trials” and “Phases of Clinical Trials”.
Patients who volunteer to take part in a clinical study are followed closely by their health care professionals and members of the research team. For more information see “Research Team Members”.
At NRG Oncology, we focus on conducting clinical studies aimed to improve current cancer care practices and the lives of cancer patients. NRG Oncology partners with more than 1,300 member sites world-wide to research ways to improve treatment standards in the cancer community. Our organization is supported primarily through grants from the National Cancer Institute (NCI) and is one of five research groups in the NCI's National Clinical Trial's Network.